Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics.
Dr. Kenneth Blum, Chief Scientific Officer of Salugen will discuss the generational association of genes associated with Reward Deficiency Syndrome (RDS). Numerous studies have revealed an association between certain dopaminergic gene polymorphisms and a number of reward dependent behaviors including addictive, compulsive and impulsive tendencies. These interrelated reward-dependent behaviors involving dopaminergic genes have been classified as RDS.
Additionally, he will present findings corresponding to multi-factorial phenotypes associated with the genes including ADHA, alcoholism, cocaine dependence, intravenous drug dependence, carbohydrate binging, smoking, hyperactivity, sex addiction, pathological violence, Tourette Syndrome, autism, and other personality disorders in an experimental group of 55 subjects derived from up to five generations of two independent multiple- affected families.
Salugen CEO Brian Meshkin states, "We are pleased to present Salugen's continued research on RDS. These findings aid us in furthering the clinical application of the research to assist those with a genetic predisposition to conditions associated with RDS."
Salugen currently markets DNA-customized nutritional solutions under three brands, GenoTrim(TM) for weight management (http://www.genotrim.com/), SpaGen(TM) for optimal health and wellness (http://www.spagen.com/) and Haveos(TM) for substance abuse attenuation.
Salugen, Inc., a leading personalized health and wellness company, engages in the discovery, development and commercialization of patent-protected genetic tests and companion DNA-customized therapeutics worldwide. With over 30 years of research conducted on the genetic causes and pharmacology of many healthcare concerns, Salugen is a pioneer and leader in delivering personalized medicine. Currently, the Company commercializes nutrigenomic technologies where genetic analysis guides the formulation and delivery of nutritional solutions that are customized to the individual. The company has headquarters in San Diego, CA, with its high-complexity CLIA-certified laboratory services in Los Angeles, CA. For additional information about the company, please visit http://www.salugen.com/.
CONTACT: Salugen, Inc., +1-858-535-4825, or fax, +1-858-535-4890
Web site: http://www.salugen.com/
|Printer friendly Cite/link Email Feedback|
|Date:||Oct 8, 2007|
|Previous Article:||Viridian Named 'High-Rise Project of the Year'.|
|Next Article:||Naval CNO Visits Philadelphia's Navy League.|